EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention
- Publication date
- 21 April 2016
- Publisher
- Henry Ford Health System Scholarly Commons